AU Patent

AU2015311704B2 — Methods and compositions for attenuating gene editing anti-viral transfer vector immune responses

Assigned to Cartesian Therapeutics Inc · Expires 2021-12-09 · 4y expired

What this patent protects

Provided herein are methods and related compositions for administering viral transfer vectors and antigen-presenting cell targeted immunosuppressants.

USPTO Abstract

Provided herein are methods and related compositions for administering viral transfer vectors and antigen-presenting cell targeted immunosuppressants.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015311704B2
Jurisdiction
AU
Classification
—
Expires
2021-12-09
Drug substance claim
No
Drug product claim
No
Assignee
Cartesian Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.